TerminatedNCT02717130

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Medication studyAges 18–65United StatesSchizophrenia

The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

The study group receives aripiprazole as a study medication.

Listed locations: Columbia and 3 more locationsSee all locations and recruitment

Get this study by email

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 8, 2016

Recruitment status: Terminated
Enrollment listed in the registry: 9
Sponsor: Florida Atlantic University
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 65 Years
Official registry ID: NCT02717130
Official title: Show the full official title
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Recruitment & locations

Terminated

Columbia · Kansas City · Springfield

1 more locations

St Louis

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Florida Atlantic University, a university.

Does this study involve medication?

Yes. The study involves medication, including Aripiprazole.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies